• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病(NAFLD)患者短链脂肪酸(SCFA)水平与瞬时弹性成像值及受控衰减参数的相关性

Correlation of Short Chain Fatty Acid (SCFA) Levels with Transient Elastography Values and Controlled Attenuation Parameters in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD).

作者信息

Astari Desi, Jasirwan Chyntia Olivia Maurine, Lesmana Cosmas Rinaldi Adithya, Simadibrata Marcellus, Kurniawan Juferdy, Yunihastuti Evy, Harimurti Kuntjoro, Nugroho Pringgodigdo

机构信息

Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.

Hepatobiliary Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.

出版信息

Acta Med Indones. 2025 Apr;57(2):167-174.

PMID:40641201
Abstract

BACKGROUND

The current hypothesis regarding the mechanism of Non-Alcoholic Fatty Liver Disease (NAFLD) is the multiple hit theory, where one of the factors involved is gut microbiota. Short-chain fatty acid (SCFA) is the main metabolite of gut microbiota and is suspected to play a role in the development of NAFLD. This study aims to determine the correlation between SCFA levels (acetate, propionate, butyrate) and the degree of fibrosis and steatosis in patients with NAFLD assessed by controlled attenuation parameter (CAP) and transient elastography (TE).

METHODS

A cross-sectional study that included 33 consecutively selected patients at Cipto Mangunkusumo Hospital was conducted from January to August 2023. Fecal sample collection was performed for SCFA examination using GC-MS (Gas Chromatography-Mass Spectrometry). Absolute fecal SCFAs were analyzed for correlation with steatosis and fibrosis based on controlled attenuation parameter (CAP) and transient elastography (TE) values.

RESULTS

Subjects were predominantly female (51.5%), with an average age of 49 years, an average CAP value of 296 dB/m, and a median transient elastography value of 6.1 kPa. The ratio of acetate, propionate, and butyrate values in the subjects was 59:24:17. A moderate negative correlation was observed between the absolute butyrate and CAP values (r=-0.522; p=0.002).

CONCLUSION

There is no correlation was identified between short-chain fatty acid levels and transient elastography values.

摘要

背景

目前关于非酒精性脂肪性肝病(NAFLD)发病机制的假说是多重打击理论,其中涉及的一个因素是肠道微生物群。短链脂肪酸(SCFA)是肠道微生物群的主要代谢产物,被怀疑在NAFLD的发展中起作用。本研究旨在确定通过受控衰减参数(CAP)和瞬时弹性成像(TE)评估的NAFLD患者中SCFA水平(乙酸盐、丙酸盐、丁酸盐)与纤维化和脂肪变性程度之间的相关性。

方法

2023年1月至8月在西托·曼古库苏莫医院进行了一项横断面研究,连续选取了33例患者。采集粪便样本,使用气相色谱 - 质谱联用仪(GC - MS)进行SCFA检测。基于受控衰减参数(CAP)和瞬时弹性成像(TE)值,分析粪便中SCFA的绝对含量与脂肪变性和纤维化的相关性。

结果

受试者以女性为主(51.5%),平均年龄49岁,平均CAP值为296 dB/m,瞬时弹性成像值中位数为6.1 kPa。受试者中乙酸盐、丙酸盐和丁酸盐值的比例为59:24:17。观察到丁酸盐绝对含量与CAP值之间存在中度负相关(r = -0.522;p = 0.002)。

结论

未发现短链脂肪酸水平与瞬时弹性成像值之间存在相关性

相似文献

1
Correlation of Short Chain Fatty Acid (SCFA) Levels with Transient Elastography Values and Controlled Attenuation Parameters in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病(NAFLD)患者短链脂肪酸(SCFA)水平与瞬时弹性成像值及受控衰减参数的相关性
Acta Med Indones. 2025 Apr;57(2):167-174.
2
Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis.累积甲氨蝶呤剂量与有中重度银屑病病史患者的肝纤维化无关。
Br J Dermatol. 2024 Jul 16;191(2):275-283. doi: 10.1093/bjd/ljae069.
3
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.非酒精性肝病患者小肠细菌过度生长的患病率:NAFLD、NASH、纤维化、肝硬化-系统评价、荟萃分析和荟萃回归。
Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261.
4
Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations.瞬时弹性成像技术在肝纤维化诊断中的应用:经济评估的系统评价
Liver Int. 2017 Jun;37(6):851-861. doi: 10.1111/liv.13260. Epub 2016 Oct 24.
5
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.应用磁共振弹性成像对非酒精性脂肪性肝病纤维化分期的截止值和混杂因素进行个体患者数据的荟萃分析。
J Hepatol. 2023 Sep;79(3):592-604. doi: 10.1016/j.jhep.2023.04.025. Epub 2023 Apr 29.
6
Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Subgroup Insights from an Interventional Study.探索口服丁酸盐补充剂在代谢功能障碍相关脂肪性肝病中的潜力:一项干预性研究的亚组见解
Int J Mol Sci. 2025 Jun 10;26(12):5561. doi: 10.3390/ijms26125561.
7
[Study of the role of biomarkers in determining the course of non-alcoholic fatty liver disease in children with obesity].[生物标志物在确定肥胖儿童非酒精性脂肪性肝病病程中的作用研究]
Vopr Pitan. 2025;94(2):85-96. doi: 10.33029/0042-8833-2025-94-2-85-96. Epub 2025 Mar 17.
8
Assessing Fibrosis and Steatosis utilizing Transient Elastography (Fibroscan) in Metabolic-dysfunction Associated Steatotic Liver Disease: An Experience from UBTH, Benin City, Nigeria.在代谢功能障碍相关脂肪性肝病中利用瞬时弹性成像(Fibroscan)评估肝纤维化和脂肪变性:来自尼日利亚贝宁城UBTH的经验
West Afr J Med. 2025 Feb 28;42(2):127-136.
9
Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.疑似酒精性肝病患者肝纤维化无创诊断评估工具的系统评价和经济评估。
Health Technol Assess. 2012;16(4):1-174. doi: 10.3310/hta16040.
10
Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.非酒精性脂肪性肝病(NAFLD)的药物干预:一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 30;3(3):CD011640. doi: 10.1002/14651858.CD011640.pub2.